Preeti Sudheendra: Lifestyle Medicine as a Core in Breast Cancer Survivorship Care
Preeti Sudheendra, Clinical Director of Late Phase Breast Cancer Drug Development at Merck, shared on LinkedIn about a recent paper by Laura E Wright published on The Oncologist:
“We are officially in print! Check out this review article in The Oncologist Journal with comprehensive, evidence-based information about the benefits of lifestyle medicine counseling and interventions for breast cancer survivors to improve quality of life as well as reduce cancer-related morbidity and mortality.
Lifestyle modification isn’t easy or quick or a single event. It doesn’t come as a pill or injection or procedure. It is the hard daily work of taking intentional actions to improve our physical, mental, and emotional well-being. But the investment is worth the pay off.
Lifestyle medicine implementation is not easy or quick either – it takes time and resources with no immediate monetary profit. But it must be done. We are doing a disservice to ourselves, our patients, our clinics, and our healthcare system by not mandating that lifestyle medicine be a core part of every Survivorship clinic and beyond.”
Title: Evidence for the benefits of lifestyle medicine interventions in breast cancer survivorship
Authors: Laura E Wright , Preeti Sudheendra
Read the full article.
More posts featuring Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023